Clinical Trial Update: Safety and Efficacy of Nateglinide in Patients With Type 2 Diabetes Already Taking Insulin Glargine, Metformin and/or Pioglitazone or Rosiglitazone [Phase 4]

View source ↗

Summary

Phase 4 trial assessing the safety and efficacy of nateglinide in people with type 2 diabetes already taking insulin glargine and/or metformin or a thiazolidine…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• Nateglinide (Starlix) (nateglinide)

Snippet

Sponsor: Novartis Pharmaceuticals | Conditions: Type 2 Diabetes | Phase 4 | Status: COMPLETED